Several molecules and indications were approved in April 2021 by FDA. Among the key approvals are the following: Accelerated approval...
FDA approvals
Five new indications/molecules were approved by FDA in March 2021 including the following: Idecabtagene vicleucel for the treatment of adult...
Six new indications/molecules were approved by FDA in February 2021 including the following: Melphalan flufenamide in combination with dexamethasone for adult...
